Literature DB >> 11220676

IL-12, IFN-gamma, and TNF-alpha released from mononuclear cells inhibit the spread of varicella-zoster virus at an early stage of varicella.

S Torigo1, T Ihara, H Kamiya.   

Abstract

The activity of mononuclear cells to inhibit plaque formation of varicella-zoster virus (VZV) was investigated by an in vitro infectious center assay. Peripheral blood mononuclear cells (PBMC) inhibited VZV plaque formation by co-cultivation with VZV-infected fibroblasts. As compared to mononuclear cells from normal individuals, mononuclear cells from umbilical cord blood and from patients receiving corticosteroids showed a significant decrease in the ability to inhibit viral replication. This ability was significantly increased for mononuclear cells collected during the acute phase of varicella. PBMC obtained from patients in the acute phase of varicella produced significantly higher amounts of interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, and interleukin (IL)-12 in the supernatant compared with those of healthy individuals. These data suggest that the cytokines have an important role in the inhibition of the spread of VZV at an early stage of varicella. Th1 type adaptive immunity might play a major role in VZV infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11220676     DOI: 10.1111/j.1348-0421.2000.tb02599.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  19 in total

Review 1.  Herpes zoster and the search for an effective vaccine.

Authors:  N Arnold; I Messaoudi
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

2.  A 1,100-year-old founder effect mutation in IL12B gene is responsible for Mendelian susceptibility to mycobacterial disease in Tunisian patients.

Authors:  Imen Ben-Mustapha; Meriem Ben-Ali; Najla Mekki; Etienne Patin; Christine Harmant; Jihène Bouguila; Houda Elloumi-Zghal; Abdelaziz Harbi; Mohamed Béjaoui; Lamia Boughammoura; Jalel Chemli; Mohamed-Ridha Barbouche
Journal:  Immunogenetics       Date:  2013-10-15       Impact factor: 2.846

Review 3.  Herpesviral infection and Toll-like receptor 2.

Authors:  Ming-sheng Cai; Mei-li Li; Chun-fu Zheng
Journal:  Protein Cell       Date:  2012-08-04       Impact factor: 14.870

4.  Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2.

Authors:  Jennifer P Wang; Evelyn A Kurt-Jones; Ok S Shin; Michael D Manchak; Myron J Levin; Robert W Finberg
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Interferon Gamma Prolongs Survival of Varicella-Zoster Virus-Infected Human Neurons In Vitro.

Authors:  Nicholas L Baird; Jacqueline L Bowlin; Taylor J Hotz; Randall J Cohrs; Don Gilden
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

6.  Interleukin-6 and type 1 interferons inhibit varicella zoster virus replication in human neurons.

Authors:  Christina N Como; Catherine M Pearce; Randall J Cohrs; Nicholas L Baird
Journal:  Virology       Date:  2018-07-04       Impact factor: 3.616

7.  Interferon Gamma Inhibits Varicella-Zoster Virus Replication in a Cell Line-Dependent Manner.

Authors:  Akhalesh K Shakya; Seong K Kim; Dennis J O'Callaghan
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

8.  Varicella-zoster virus modulates NF-kappaB recruitment on selected cellular promoters.

Authors:  Nadia El Mjiyad; Sébastien Bontems; Geoffrey Gloire; Julie Horion; Patricia Vandevenne; Emmanuel Dejardin; Jacques Piette; Catherine Sadzot-Delvaux
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

9.  Varicella-zoster virus infection induces the secretion of interleukin-8.

Authors:  Nathalie Desloges; Christiane Schubert; Manfred H Wolff; Markus Rahaus
Journal:  Med Microbiol Immunol       Date:  2007-10-02       Impact factor: 3.402

10.  Cellular Stress Response to Varicella-Zoster Virus Infection of Human Skin Includes Highly Elevated Interleukin-6 Expression.

Authors:  Keith W Jarosinski; John E Carpenter; Erin M Buckingham; Wallen Jackson; Kevin Knudtson; Jennifer F Moffat; Hirohito Kita; Charles Grose
Journal:  Open Forum Infect Dis       Date:  2018-05-22       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.